These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19173369)

  • 1. Drug delivery by an enzyme-mediated cyclization of a lipid prodrug with unique bilayer-formation properties.
    Linderoth L; Peters GH; Madsen R; Andresen TL
    Angew Chem Int Ed Engl; 2009; 48(10):1823-6. PubMed ID: 19173369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase A(2)-susceptible liposomes of anticancer double lipid-prodrugs.
    Arouri A; Mouritsen OG
    Eur J Pharm Sci; 2012 Mar; 45(4):408-20. PubMed ID: 21946258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer double lipid prodrugs: liposomal preparation and characterization.
    Arouri A; Mouritsen OG
    J Liposome Res; 2011 Dec; 21(4):296-305. PubMed ID: 21438721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic study of the sPLA2-mediated hydrolysis of a thio-ester pro anticancer ether lipid.
    Linderoth L; Fristrup P; Hansen M; Melander F; Madsen R; Andresen TL; Peters GH
    J Am Chem Soc; 2009 Sep; 131(34):12193-200. PubMed ID: 19663381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier.
    Sagi A; Segal E; Satchi-Fainaro R; Shabat D
    Bioorg Med Chem; 2007 Jun; 15(11):3720-7. PubMed ID: 17416532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
    Schroeder A; Kost J; Barenholz Y
    Chem Phys Lipids; 2009 Nov; 162(1-2):1-16. PubMed ID: 19703435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery.
    Kaasgaard T; Andresen TL; Jensen SS; Holte RO; Jensen LT; Jørgensen K
    Chem Phys Lipids; 2009 Feb; 157(2):94-103. PubMed ID: 19094974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
    Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
    J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs.
    Pedersen PJ; Christensen MS; Ruysschaert T; Linderoth L; Andresen TL; Melander F; Mouritsen OG; Madsen R; Clausen MH
    J Med Chem; 2009 May; 52(10):3408-15. PubMed ID: 19402667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and pharmacological effects of a cyclization-activated steroid prodrug for colon targeting in inflammatory bowel disease.
    Ruiz JF; Radics G; Windle H; Serra HO; Simplício AL; Kedziora K; Fallon PG; Kelleher DP; Gilmer JF
    J Med Chem; 2009 May; 52(10):3205-11. PubMed ID: 19397323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squalenoyl prodrug of paclitaxel: synthesis and evaluation of its incorporation in phospholipid bilayers.
    Sarpietro MG; Ottimo S; Paolino D; Ferrero A; Dosio F; Castelli F
    Int J Pharm; 2012 Oct; 436(1-2):135-40. PubMed ID: 22728161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriorhodopsin conjugates as anchors for supported membranes.
    Sharma MK; Jattani H; Gilchrist ML
    Bioconjug Chem; 2004; 15(4):942-7. PubMed ID: 15264886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers.
    Sarpietro MG; Ottimo S; Giuffrida MC; Rocco F; Ceruti M; Castelli F
    Int J Pharm; 2011 Mar; 406(1-2):69-77. PubMed ID: 21219999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal formulation of retinoids designed for enzyme triggered release.
    Pedersen PJ; Adolph SK; Subramanian AK; Arouri A; Andresen TL; Mouritsen OG; Madsen R; Madsen MW; Peters GH; Clausen MH
    J Med Chem; 2010 May; 53(9):3782-92. PubMed ID: 20405849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs.
    Fouladi F; Steffen KJ; Mallik S
    Bioconjug Chem; 2017 Apr; 28(4):857-868. PubMed ID: 28201868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of self-immolative linkers for tumour-activated prodrug therapy.
    Tranoy-Opalinski I; Fernandes A; Thomas M; Gesson JP; Papot S
    Anticancer Agents Med Chem; 2008 Aug; 8(6):618-37. PubMed ID: 18690826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy.
    Karve S; Alaouie A; Zhou Y; Rotolo J; Sofou S
    Biomaterials; 2009 Oct; 30(30):6055-64. PubMed ID: 19665223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The delivery and antinociceptive effects of morphine and its ester prodrugs from lipid emulsions.
    Wang JJ; Sung KC; Yeh CH; Fang JY
    Int J Pharm; 2008 Apr; 353(1-2):95-104. PubMed ID: 18158222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of bilayer vesicles by self-assembly.
    Walker SA; Kennedy MT; Zasadzinski JA
    Nature; 1997 May; 387(6628):61-4. PubMed ID: 9139822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modular theranostic prodrug based on a FRET-activated self-immolative linker.
    Redy O; Shabat D
    J Control Release; 2012 Dec; 164(3):276-82. PubMed ID: 22580227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.